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Background/aim: It is not always possible to determine the causative basis of pregnancy losses and even today it has been reported
that 50% of cases with recurrent pregnancy loss (RPL) have no reason to be detected. In our study, it is aimed to reveal the copy
number variations (CNVs) of the genes which presumably have a potential effect in individuals with RPL and contribute to subsequent
functional studies in the follow-up.
Materials and methods: We retrospectively evaluated the array-comparative genomic hybridization (aCGH) data of cytogenetically 64
normal individuals (21 couples, 11 unrelated women, and 11 unrelated men) who had applied to our outpatient clinic from January 2016
to December 2017, for the history of idiopathic two or more RPL.
Results: A total of 83 CNVs were detected in 56 different chromosomal regions [36% (20/56) is deletion and 64% (36/56) is duplication]
in 40/64 (62.5%) of the cases. Two detected deleterious CNVs encompassing 1p36.22-p36.21 and 10q11.22 chromosomal locus have
been reported as pathogenic according to the Database of Genomic Variants (DGV).
Conclusion: CNVs that may play a role in the genetic etiology of idiopathic RPL were revealed in our study and potential chromosomal
loci were introduced to the literature for further analysis. The detection of CNVs and their association with reproduction such as RPL,
infertility, and even other diseases will allow us to have more information about the clinical consequences and will make it possible to
provide more accurate and comprehensive genetic counseling.
Key words: Array-comparative genomic hybridization, copy number variation, recurrent pregnancy loss

1. Introduction
The 15%–25% of pregnancies end up with a miscarriage
and 3%–5% of pregnancy losses are recurrent [1,2].
Recurrent pregnancy loss (RPL) is defined as the loss of two
or more pregnancies before the 20th week of gestation [3–
5]. However, some publications suggest that there should
be three pregnancy losses for RPL and then recommend
evaluation [6]. RPL is a troublesome condition for couples
because the probability of miscarriage increases gradually
after each pregnancy loss [7].
It is not always possible to determine the underlying
cause of pregnancy losses. No causative factor could be
identified in up to 50% of cases with a history of RPL [8,9].
This group is classified as idiopathic RPL. Prospective
and retrospective studies reveal that women who had a
previous pregnancy with loss/abortion faced an increased
risk of loss in the next pregnancy [7]. RPL prevalence
among the first-degree relatives of idiopathic pregnancy
loss patients increased 6-fold compared to the general
population [10].

Copy number variations (CNVs) are very common in
the population. Some CNVs are considered benign, while
some are variants that reflect the patient’s phenotype.
There are also a large number of rare CNVs with unknown
phenotypic consequences. As a result, the interpretation
of rare variants of unknown clinical significance causes
great difficulty. In this respect, international databases
have been established to collect as much data as possible
and to share information among experts. However, general
literature information of some CNVs for the potential
etiological cause associated with RPL is not sufficient.
CNVs can affect the gene dosages that are critical in early
gestation or disrupt segregation of chromosomes, resulting
in miscarriages [11].
Large perisentromeric and subtelomeric CNVs may
predispose to idiopathic RPL. In the genomes of patients
with idiopathic RPL, almost twice as much CNVs [>300
kilobase (kb)] were detected compared to the controls.
In particular, 63% of these large CNVs (>300 kb) in
subjects with idiopathic RPL are in pericentromeric

* Correspondence: onuryildiz89@hotmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

1689

YILDIZ et al. / Turk J Med Sci
and subtelomeric regions, whereas only 33% of the
large CNVs detected in control parental genomes are in
perisentromeric and subtelomeric regions [12].
In order to detect the changes in the number of copies
of cases with RPL, we should perform analyses at higher
resolutions. CNVs can be detected using the arraycomparative genomic hybridization (aCGH) technique
without a need of cell culture.
With the aCGH approach, new candidate genes
causing recurrent miscarriages can be found. Analysis of
which pathways the detected genes belong to (thrombosis,
immunological, placental development, etc.) will be useful
in the follow-up of patients [12]. It will also be possible
to develop new strategies on candidate genes. In this
way, it will enable the patients in this group to get a more
advanced and effective diagnosis.
2. Materials and methods
2.1. Patient recruitment
In this study, we evaluated the data of 64 patients (21
couples, 11 unrelated women, and 11 unrelated men)
with idiopathic RPL obtained by the aCGH method in
terms of their CNVs who had applied to the Çanakkale
Onsekiz Mart University Medical Genetics outpatient
clinic from January 2016 to December 2017. All the
cases included in this study had demonstrated normal
karyotypes.
All experimental procedures were conducted in
accordance with the principles of the Declaration of
Helsinki, and informed written consent was obtained
from patients or their guardians. This was a retrospective
clinical study approved by Çanakkale Onsekiz Mart
University Clinical Research Ethics Committee with the
decision numbered 20-06 and dated December 13, 2017.
2.2. DNA isolation
Genomic DNA had been extracted from the peripheral
blood of all patients using QIAamp DNA Blood Mini
QIAcube Kit (Qiagen, Hilden, Germany) according to the
standard procedures. After the isolation, concentrations
of the patient DNAs and reference DNA samples were
measured with NanoPhotometer® P330 (Implen, Westlake
Village, CA, USA) and then the concentrations of all
samples were adjusted to 50 ng.
2.3. Chromosomal microarray
SurePrint G3 ISCA V2 CGH 8 × 60K (Agilent Technologies,
Santa Clara, CA, USA) slide was used for the aCGH study.
Labeling, prehybridization preparation, hybridization at
67 °C for 24 h, washing and slide scanning with Agilent
Microarray Scan Control software (Agilent Technologies,
Santa Clara, CA, USA) steps were implemented before the
analysis.
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2.4. Analysis
Feature Extraction 12.0.1.1 software (Agilent Technologies,
Santa Clara, CA, USA), which also provided the quality
control report of the study, was used to convert the
“.tiff ” files to mathematical data after scanning. Agilent
CytoGenomics 4.0 software (Agilent Technologies, Santa
Clara, CA, USA) was utilized for the analysis.
The mean log ratios of at least three probes were
determined as a threshold limit > 0.5 for a duplication and
<–0.5 for a deletion.
2.5. Statistics
The data were analyzed using IBM SPSS Statistics for
Windows, version 20.0 (IBM Corp, Armonk, NY, USA).
Percentage, median, mean, standard deviation (SD),
minimum, and maximum were used for the identification
of descriptive data. The detected CNVs were compared with
the Database of Genomic Variants (DGV). Chi-squared and
ANOVA tests were used for statistical comparison of the
groups. In cases where the assumptions of the ANOVA test
were not met, the Kruskal–Wallis nonparametric test was
done. As a result of statistical comparison of CNVs, regions
with p < 0.05 were considered statistically significant.
3. Results
The characteristics of our cases with idiopathic RPL are
presented in Table 1.
Mean age and median of the study group was 33.9 ±
6.6 and 33.5 (min: 22.0; max: 55.0) years respectively. The
number of female and male patients included in the study
is both 32; the mean age is 32 years for the female, 36 years
for the male.
Significant CNVs were detected in 40 (~62%) of total
64 individuals (Table 2). In these 40 cases, a total of 83
CNVs were detected in 56 different regions [36% (20/56)
is deletion and 64% (36/56) is duplication (Figure 1)].
There were no CNVs detected in the 18, 20, 21, X, and Y
chromosomes (Figure 2). It was observed that the detected
CNVs were generally spanning between 100 and 500 kb, and
no CNV was detected below 10 kb and above 2 megabase
(Mb). CNV containing LINC01237 and LOC102723927
gene regions was detected in eight individuals as it was
the most common CNV in our patient group (Figure 3).
In one case, a heterozygous deletion was detected in the
10q11.22 chromosome region containing GPRIN2, NPY4R,
ANXA8 genes, and in another case, a heterozygous deletion
was observed including TNFRSF8, TNFRSF1B, and DHRS3
genes in the 1p36.22-p36.21 chromosome region (Figure 4)
further confirmed with SALSA MLPA P147 1p36 probemix
(MRC-Holland BV, Amsterdam, the Netherlands) (Figure
5). These two CNVs have been reported as pathogenic in
many databases (ClinVar and DGV etc.). Other remaining
detected CNVs have been regarded as benign and possible
benign in the literature.
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Table 1. Demographic characteristics of our cases with idiopathic RPL.
n (%)
Sex
Female

32 (50.0)

Male

32 (50.0)

Level of education
Illiterate/No formal education

1 (1.7)

Up to primary school

10 (16.9)

Up to middle school

8 (13.6)

Up to high school

19 (32.2)

University

21 (35.6)

Individual having children alive
Yes

27 (42.9)

No

36 (57.1)

Family history of RPL
Present

8 (12.5)

Absent

56 (87.5)

History of congenital anomaly in the family
Present

12 (18.8)

Absent

52 (81.3)

Family history of learning disabilities
Present

6 (9.4)

Absent

58 (90.6)

Consanguineous marriages
Yes

12 (18.8)

No

52 (81.3)

Table 2. CNV distributions of our subjects with idiopathic RPL.
CNV not detected CNV detected CNV with gene Gene-free CNV CNV both with gene and gene-free
n (%)
n (%)
n (%)
n (%)
n (%)
Number of cases

24 (37.5)

40 (62.5)

37 (57.8)

3 (4.6)

11 (17.1)

Number of male cases

10 (15.6)

22 (34.3)

20 (31.2)

2 (3.1)

5 (7.8)

Number of female cases 14 (21.8)

18 (28.1)

17 (26.5)

1 (1.5)

6 (9.3)

Genes detected in CNV regions in two or more cases
were evaluated by comparing with the genes detected in
the population ratios in DGV database (Table 3). These
genes include LINC01237, LOC102723927, ZRANB2AS, LINC01566, NEGR1, FRG2DP, CYP2E1, DUSP22,
CATSPER2, UPK3B, POMZP3, PSG8, PSG1, PSG6, PSG7,
PSG11, PSG2, PSG5, PSG4, and the CNVs including these
gene regions have been evaluated as benign or probable
benign in ClinVar.

In cases with up to 4–12-week pregnancy loss, the
number of cases with CNV was 24 (64%), and 23 (62%)
of these cases with CNV regions contained genes, 7 (18%)
cases had gene-free CNV regions. Six of these cases had
both gene-containing region and gene-free region. In
cases with up to 13–24-week pregnancy loss, the number
of cases with CNV was 13 (68%), and 12 (63%) of these
cases with CNV regions contained genes, 2 (10%) cases
have gene-free CNV regions. A single case had both gene-
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q2 6.32
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q1 1.23
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q2 3.31
q2 6.3
q2 5
p1 2.3
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q2 4.32
q3 1.1
q1 1.2
q1 2
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p1 1.2-p1 1.1
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Figure 1. CNV distributions according to the sizes and mutation
types (deletion or duplication) detected in our individuals with
idiopathic RPL.

Figure 2. Distribution of CNVs according to the chromosomal
loci detected in our individuals with idiopathic RPL.

Figure 3. aCGH image of heterozygous deletion (150Kb)
containing LINC01237, LOC102723927 genes at 2q37.3 locus in
eight cases with a history of RPL.

Figure 4. aCGH image of p36.22-p36.21 locus at chromosome 1
containing TNFRSF8, TNFRSF1B, DHRS3, MIR7846, MIR4632,
VPS13D, SNORA59A, SNORA59B, MIR6730, AADACL4,
AADACL3, C1orf158, PRAMEF12, PRAMEF1, PRAMEF11,
HNRNPCL1, HNRNPCL3, HNRNPCL4 in a case with RPL
history shows heterozygous deletion (792 Kb).

Figure 5. MLPA analysis showing the heterozygous deletion of TNFRSF1B gene located in 1p36.22-p 36.21 (A and B).
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containing region and gene-free region in this group. In
cases with up to ≥25-week pregnancy loss (stillbirth), the
number of cases with CNV was 3 (37%) and 2 (25%) of
these cases with CNV regions contained genes, 2 (25%)
cases had gene-free CNV regions. A single case had both
gene-containing region and gene-free region in this group
(Figure 6).
In cases with 2–3 pregnancy losses, the number of
cases with CNV was 29 (63%) and 26 (56%) of these cases
with CNV regions contained genes, 8 (17%) cases had

gene-free CNV regions. Five of these cases had both genecontaining region and gene-free region. In cases with 4 or
more pregnancy losses, the number of cases with CNV was
11 (61%) and 11 (61%) of these cases with CNV regions
contained genes, 3 (16%) cases had gene-free CNV regions.
Three of these cases had both gene-containing region and
gene-free region. There were no significant differences
between the cases with 2–3 pregnancy losses and those
with 4 or more pregnancy losses in terms of detected CNV
number (Figure 7).

Table 3. Comparing the genes detected in our study with the ratios in DGV database.

GENES

Our study
(number of
detected cases/
total case)

DGV database
(number of detected p
cases/total case)

Reference

LINC01237, LOC102723927

Del

8/64

41/771

0.020

dgv165e55

ZRANB2-AS2

Dup

4/64

1/112

0.003

nsv818211

LINC01566

Dup

4/64

13/29084

0.0001

dgv2963n100

NEGR1

Dup

3/64

2/1557

0.0001

dgv19n27

FRG2DP

Dup

3/64

189/29084

0.009

dgv2965n100

CYP2E1

Dup

3/64

110/29084

0.002

dgv1001n100

DUSP22

Del

2/64

84/29084

0.015

dgv5878n100

UPK3B, POMZP3

Del

2/64

3/112

0.514

dgv63n64

CATSPER2

Del

2/64

17/29084

0.002

dgv2585n100

PSG1, PSG2, PSG4, PSG5, PSG6, PSG7,
PSG8, PSG11

Dup

2/64

16/771

0.384

dgv140e55

Up to 13-24
week
Up to 4-12
week

Pregnacy Loss

Up to ≥25
week
(stillbirth)

p: Binomial test; del: deletion; dup: duplication
Values in bold are admitted statistically significant (p < 0.05).

Gene free CNV
CNV with gene
CNV detected
Total Case
Gene free CNV
CNV with gene
CNV detected
Total Case
Gene free CNV
CNV with gene
CNV detected
Total Case

25%
25%
37.5%

45
40

63.1%

35

68.4%

30

100%

25

18.9%

20

62.1%

15

64.8%

0

Number of Cases

50
100%

10.5%

5

10

15

20

25

30

35

100%

10

40

5

Up to 4-12 week
Up to 13-24 week
Up to ≥25 week (stillbirth)
CNV
CNV
CNV
Total
CNV
Gene
Total
CNV
Gene
Total
CNV
Gene
with
with
with
Case detected
free CNV Case detected
free CNV Case detected
free CNV
gene
gene
gene
37
24
23
7
19
13
12
2
8
3
2
2

Figure 6. CNV distributions according to the week of pregnancy
loss detected in our individuals with idiopathic RPL.

0
Total case

CNV
detected

CNV with Gene free
CNV
Total case
gene
CNV
detected

In cases with 2-3 pregnancy losses
Number of Cases

46

29

26

CNV with Gene free
gene
CNV

In cases with 4 or more pregnancy losses
8

18

11

11

3

Figure 7. CNV distributions according to the number of
pregnancy loss detected in our individuals with RPL.
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4. Discussion
The 1%–3% of couples wanting to have a child may
encounter RPL. RPL is a polygenic, multifactorial health
burden with anatomical, endocrine, immunological,
infectious, thrombophilic (both acquired and congenital),
genetic, and environmental basis in the etiology [13]. The
main first-tier genetic tests performed to elucidate causative
factors of RPL are chromosome analysis of the peripheral
blood sample of women and men, and SNP analysis of FV
and F2 genes of women in terms of thrombophilia [14].
Even if all of these factors are examined, approximately
50% of underlying causes of RPL remains idiopathic.
Therefore, further comprehensive studies are needed to
determine the etiology of RPL.
aCGH, or so-called chromosomal karyotyping, is
a high-resolution and genome-wide analysis method
enabling to detect CNVs within DNA sequence. Most
CNVs are polymorphic. The genome content of any
two individual may vary up to 50–100 Mb due to CNV
polymorphism. CNVs are important because they lead to
a couple of consequences in chromosomal rearrangements
and they can also affect the phenotype depending on
whether they contain a gene or not. To date, such a few
studies have been conducted to evaluate CNVs in the cases
with RPL [12,15–17].
In the study by Rajcan-Separovic et al., 22 individuals
were studied with the aCGH method (Agilent® 105K
microarray). Eleven previously undetected CNVs were
found on 8 pairs, 13 fetal materials. In our study, the
CNV regions were not detected in the same chromosomal
regions compared with the CNVs detected in that study;
this may be due to the limited number of cases included
for the study or the ethnic difference between two patient
groups [15].
A total of 558 cases of RPL and 205 healthy female
controls were included in the study by Nagirnaja et al.,
albeit no male control subjects were recruited. In their
study, a new duplication was detected in the 5p13.3
chromosome region and it was suggested that changes in
the expression of PDZD2 and GOLPH3 genes may be a risk
factor increasing pregnancy complications [16]. In our
study, no variations were detected in these regions. The
study of Nagirnaja et al. has the largest patient and control
group in the medical literature, and our sample group is
relatively small.
Twenty-five cases with idiopathic RPL were included
in the study conducted by Kasak et al., and maternal,
paternal, and placental genetic factors were investigated.
NUP98 and MTRR genes have been shown to be effective
in cases with RPL, and it has been reported that large
pericentromeric and subtelomeric CNVs may be risk
factors for RPL. Although no variation in these genes
was detected in our study, CNVs in pericentromeric and
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subtelomeric regions were also detected in our study [12].
The 16 couples and 12 female patients with RPL were
included and analyzed by cytogenetic and microarray
tests in the study conducted by Karim et al. in 2017.
Microdeletion and/or microduplication were detected in
the 8p23.1, 10q11.21-q11.22 and 15q11.2 chromosomal
regions in at least 10% of the patients included in the
study and the dosage of GSTT1, CTLAPL, HLA, and
MSR1 genes residing 22q11.23, 3p22.2, 6p21.32, and 8p22
chromosomal locations respectively have been reported to
be affected [17]. In our study, CNVs were also detected in
the chromosomal regions of 8p23.1, 10q11.21-q11.22 and
it should be remembered that these regions may pose a
risk for RPL.
The number of our cases having dosage difference in
LINC01237, LOC102723927, ZRANB2-AS, LINC01566,
NEGR1, FRG2DP, CYP2E1, DUSP22, and CATSPER2
genes were found to differ statistically significantly
compared to DGV database (p < 0.05). UPK3B, POMZP3,
PSG8, PSG1, PSG6, PSG7, PSG11, PSG2, PSG5, and PSG4
genes have not been statistically significantly different
according to the DGV (p > 0.05). It is predicted that this
may be due to the selection of cases in the DGV database,
and it is necessary to conduct studies with healthy control
groups known to be fertile to evaluate CNVs containing
these genes.
LINC01237 gene is extensively expressed in appendix,
lymph node, spleen, thyroid and endometrium tissues
[18]. Although the clinical significance of deletion in the
LOC102723927 gene region has not been fully established,
it has been suggested that it may be associated with
uncontrolled gestational diabetes [19]. These genes are long
noncoding RNA genes, and the fact that the LINC01237
gene is expressed in appendix, lymph node, and spleen
suggests that it may play a role in the immune system. The
fact that it is also extensively expressed in the endometrium
supports that it can be a particularly important candidate
gene in the etiology of pregnancy losses.
Expression of the SYCE1 gene product is most intensely
from the testicle and limitedly from the placenta, brain, and
prostate, respectively [20]. CNV in this region is classified
as VUS (variant of unknown significance) in ClinVar and
was detected in patients with a history of preeclampsia
and normal delivery [19]. Vries et al. in 2014 detected a
nonsense homozygous mutation (Q205X) at the SYCE1
gene in two sisters with premature ovarian failure [21]. In
2015, Maor-Sagie et al. revealed a homozygous mutation
at the SYCE1 gene in two Iranian brothers and associated
it with a spermatogenesis error [22]. In a study of 970
Chinese men with nonobstructive azoospermia, Huang et
al. determined 134 kb deletion at the SYCE1 gene in three
individuals and reported that it had been associated with
nonobstructive azoospermia [23].
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Avidan et al. detected 70 kb deletion in CATSPER2
gene in three brothers and reported that this was related
to nonsyndromic male infertility [24]. In a study reported
in 2013, Hoppman et al. found the percentage of those
carrying the heterozygous deletion of this gene with
a frequency of 1%; in one patient, they detected the
homozygous deletion of this gene and concluded that
the deletions of this region were associated with hearing
loss and male infertility [25]. Jaiswal et al. reported the
deletion of this gene in two infertile brothers as a case
report [26].
The CNV containing PSG8, PSG1, PSG6, PSG7, PSG11,
PSG2, PSG5, PSG4 have been evaluated as likely benign/
benign in ClinVar database. Genes in this region are
expressed in the placenta. In a study conducted by Arnold
et al. in 1999, there was a relationship between PSG11 gene
and the risk of recurrent pregnancy loss [27].
FER1L6-AS2 is largely expressed in the stomach, while
as a 2nd place it is expressed from the testicle. In the study
published by Ledig et al. in 2010, the FER1L6 gene was
reported to be associated with folliculogenesis and male
infertility [28].
In our study, sex of patients and gene-organ
expressivities were evaluated and CATSPER2, LINCO1208,
FAM27E5, FLJ36000, IMMP2L, PIWIL3, SYCE1,
FRG2DP, TP53TG3HP, ZRNAB2-AS2, and LINCO1566
were evaluated as possible paternal factors and UPK3B,
POMZP3, PSG8, PSG1, PSG6, PSG7, PSG11, PSG2, PSG5,
PSG4, ZNF595, ZNF718, ZFPM2, ZFPM2-AS1, ZDHHC14,
HAGLR, HAGLROS, LINC01237, LOC102723927,
DUSP22, and GGT3P as possible maternal factors.
Our study has a limitation. Due to the fact that we
analyzed retrospectively the data of individuals with
idiopathic RPL, it is not always possible to declare that
detected CNVs are de novo or inherited because of the
lack of CNV profiles of the placental tissues. To get more

valid information synchronous (mother-father-placenta)
CNV profile analyses of RPL cases are needed.
5. Conclusion
There has not been enough study for the CNVs detected
by aCGH approach in the possible genetic basis of RPL.
Genes that may play a role in the genetic etiology of RPL
were revealed in our study and new candidate genes were
introduced to the literature for further analysis. In addition,
genetic factors belonging not only to the mother but also
to the father were found to be important in the research
of genetic basis. Expanding and increasing research on
RPL in our country will contribute to the elucidation of
genetic causative factors. At the same time, the detection
of CNVs and their association with reproduction such
as RPL, infertility, and even other diseases will make us
have more information about the clinical consequences
and will make it possible to provide more accurate and
comprehensive genetic counseling.
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